Trial Profile
Clinical evaluation of time to re-hospitalization and renal function of tolvaptan in congestive heart failure patients with volume overload. Prospective randomized controlled trial.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Acute heart failure; Decompensated heart failure
- Focus Biomarker; Pharmacodynamics
- 02 Sep 2015 Interim results in 105 patients presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology.
- 01 Feb 2013 New trial record